학술논문

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.
Document Type
Article
Source
Neurology® Neuroimmunology & Neuroinflammation; May2022, Vol. 9 Issue 3, p1-12, 12p
Subject
Language
ISSN
23327812